Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

TheraSpecs® Announces Groundbreaking New Product Lines to Tackle Brain Injuries, Epilepsy, and More


News provided by

TheraSpecs Company

Dec 07, 2023, 15:10 ET

Share this article

Share toX

Share this article

Share toX

Group of young people wearing TheraSpecs new therapeutic lens options for light
Group of young people wearing TheraSpecs new therapeutic lens options for light

TheraSpecs® Company lights the way to a revolution in therapeutic eyewear solutions for your health, unveiling a comprehensive range of innovative lenses that offer relief for migraines, brain injuries, epilepsy, insomnia, and diverse light-related challenges.

PHOENIX, Dec. 7, 2023 /PRNewswire-PRWeb/ -- TheraSpecs® Company, the leading brand of therapeutically tinted glasses for migraine and light sensitivity, today announced multiple new product lines designed for a wide range of additional symptoms, conditions, and situations. As the first company to offer such a line direct to consumers, TheraSpecs is positioned to help millions with brain injuries, photosensitive epilepsy, insomnia, and computer headaches.

"I started TheraSpecs in 2011 to help my wife and people like her with debilitating chronic migraine," said founder and CEO, Hart Shafer. "Along the way, I have spoken with thousands of people with a wide range of experiences, from debilitating vertigo after a concussion to headaches when using their computer all day, and I'm beyond thrilled that we now have more ways to help all of them."

As the first company to offer such a line of therapeutic lenses direct to consumers, TheraSpecs is positioned to help millions with brain injuries, photosensitive epilepsy, insomnia, and computer headaches.

Post this

The significant expansion in the company's catalog includes its original indoor glasses and outdoor sunglasses, both of which elevate the FL-41 tint and deliver lasting relief to customers with migraine, light sensitivity, and other symptoms for over a decade. They've been made even better with the addition of premium optical coatings that further reduce scratches, smudges, and glare.

New to the TheraSpecs lineup are lenses that provide additional options for migraine and photophobia relief, as well as address even more issues that are triggered or worsened by light. These include light sensitivity and related symptoms due to brain injury and post-concussion syndrome, seizures triggered by flashing lights, sleep disrupted by blue light, and decreased contrast due to visual issues, plus much more.

TheraSpecs' seven lens types, are:

  • FL-Pro™, the original indoor lens, offers the strongest protection for artificial lights and digital device screens; helps reduce migraine attacks, headaches, post-concussion symptoms, and photophobia.
  • FL-Blend™ balances protection against screen and other artificial light with a less noticeable color; also helps reduce migraines, concussion symptoms, and light sensitivity.
  • Z-Blue™ protects from flashing lights and repeating patterns to provide relief for photosensitive epilepsy; often preferred by people with brain injuries as well. Available in three lens strengths to accommodate symptom severity.
  • Sleep improves circadian rhythms and enhances the quality of your sleep when worn before bedtime.
  • Flex takes the edge off triggering light with a barely-visible tint; helpful for mild light sensitivity and light enough to use for night driving.
  • Contrast HEV™ filters high-energy visible light to deliver greater contrast and sharpness to your vision.
  • FL-Sun™, the original outdoor lens, is the best sunglasses lens you've ever tried.

Most of the lens types now come in multiple strengths to further accommodate the unique needs and symptom severity of customers. Additionally, TheraSpecs offers a wide selection of frames as well as prescription and reader options.

Previously these types of tints were only available through specialty optical sources, difficult to produce accurately, and of varying quality and reliability. Now, TheraSpecs Company has combed through the research to find the best tints for different conditions and situations, and produced high-quality, tested, affordable, reliably therapeutic eyewear that can be conveniently purchased at theraspecs.com.

With these new lens offerings, more people will be able to experience the life-changing impact of TheraSpecs, like Niki, who shared this recently:

"These changed my life the moment I got them! No more daily headaches, no more light sensitivity. I feel like I can be a part of the world now at any time of day, whether indoor or outdoor, using technology, going to music events. These are hands down the best product I have ever invested in and my overall health and well-being has been positively impacted!"

Order today and experience the benefits that TheraSpecs glasses can have on your health: https://www.theraspecs.com.

Media Contact
Greg Bullock, TheraSpecs Company, 1 480-544-8320, [email protected], https://www.theraspecs.com

SOURCE TheraSpecs Company

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.